Stephen Schiltz Manager, Commercial Operations and Strategy at Ginkgo Bioworks, Inc. Germantown, Maryland, United States 399 connections As more and more schools reopen for in-person learning, the critical role of routine COVID testing is expanding exponentially. Consumer demand for meat substitutes and plant-based beverages jumped 17% last year . Meet the Ginkgo Bioworks Team. Ginkgo Bioworks raised $9000000 on 2015-03-18 in Series A. "Ginkgo Bioworks was the first life sciences company YC funded, back in 2014," Y Combinator partner Jared Friedman told me. About Ginkgo Bioworks Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow products instead of manufacturing them. Tony Luong Making microbes do our bidding. Read more Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Ginkgo Bioworks. . 27 Drydock Avenue, 8th Floor Boston, MA 02210. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. . Paul Ferris is a founding General Partner with Azure Capital Partners and has over 25 years experience working with high growth disruptive technology companies, with the past 20 years investing directly in consumer, digitally native vertical e-commerce, cloud-enabling applications and infrastructure, IoT, gaming and digital media related companies for Azure. Before the SPAC transaction, Ginkgo Bioworks had raised a total $797.8 million in financing according to Crunchbase—including a $290 million Series E financing completed in 2019. Ginkgo Bioworks (which is not exclusively Animal Health and Nutrition) clearly led this category, capturing nearly 60 percent of the funding. We have built the world's first organism engineering foundry in our 11,000 sqft facility in Boston and . Crunchbase is the leading destination for millions of users to discover industry trends, investments, and news about global companies-from startups to the Fortune 1000. . Ginkgo will use its technology to accelerate and make . But Ginkgo isn't waiting for the slow, gradual adoption of synthetic biology by old-world players. Ginkgo Bioworks is a biotech company that designs custom microbes. . Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 . One example is Bayer, which was an early investor in Pivot Bio's Series A in 2017 before it created a joint venture with microbe-farming group Ginkgo Bioworks called Joyn Bio to find microbes that might also reduce the need for nitrogen fertilizer. According to Crunchbase, . We can highlight the next thriving fund investment areas, such as Biopharma, Energy. Report issue. TechCrunch. The plant sciences startup is mainly funded through its parent companies, along with Global Viking Investors, to the tune of $200 million. Founded in 2011, Impossible Foods is focused on developing plant-based substitutes for meat and dairy products. Credit: SynBioBeta. Acquisition Ginkgo Acquires FGen AG, Ultra-High-Throughput Screening Platform March 14, 2022. Investors are still hungry for fake meat as they serve up a fresh $300 million in funding for Impossible Foods, a company best known for its plant-based "Impossible Burger." (Reuters first broke the news this morning.). September 19, 2019. While dedicated to engineering microbes to address different . FREDERICK, Md., April 16, 2021 /PRNewswire-PRWeb/ -- CIAN Diagnostics, the premier COVID-19 testing facility, is partnering with the epidemiological tracing and vaccine experts at Ginkgo Bioworks to ramp up pooled testing for schools across the country. Before the SPAC transaction, Ginkgo Bioworks had raised a total $797.8 million in financing according to Crunchbase—including a $290 million Series E financing completed in 2019. INDIANAPOLIS and BOSTON, April 1, 2021 /PRNewswire/ -- Corteva Agriscience LLC (NYSE: CTVA ), a leading pure-play . The genome mining team will move to Ginkgo's headquarters in Boston's Seaport District. The issue has been logged and we'll be looking into it ASAP. Allonnia is the third company to launch out of the Ferment Consortium, Ginkgo Bioworks' $350 million investment vehicle leveraging biology to solve global challenges and transform established . Geltor is the conscious biodesign company creating the world's most advanced designer proteins. Boston-based biotech unicorn Ginkgo Bioworks announced today it has raised a $290 million Series E.The financing takes the 10-year-old company's valuation to over $4 billion, according to Forbes.It also brings its total funding to $719 million, according to its Crunchbase profile.. Ginkgo focuses on designing and commercializing engineered strains and fermentation processes to produce cultured ingredients or specialty enzymes relevant for a . Kelly will continue to lead the company as CEO along with co-founder and president/COO, Shetty. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG) that values the company at a pre money equity value of $15 billion. Her image showed that DNA was a double helix, a twisted ladder of paired "letters" that made a molecular code. Bayer recently obtained worldwide exclusive distribution rights to AlphaBio Control's . It will take until 2085 for Black workers to reach the same hiring rate of white men in the . Warp Drive Bio is a subsidiary of Revolution Medicines.. Ginkgo Bioworks designs custom organisms across multiple markets, basically creating bacteria and fungi that churn . Founded in 2008, Ginkgo Bioworks is an industrial biotechnology company based in Boston that specializes in the development and improvement of commercially relevant microorganisms. May 20, 2020. Crunchbase is the leading destination for millions of users to discover industry trends, investments, and news about global companies-from startups to the Fortune 1000. . With the children of the company's co-founders right up front, the Ginkgo Bioworks team rang the bell of the New York Stock Exchange this morning, taking the synthetic biology company public. Bayer announced that the company is pursuing an agreement whereby Ginkgo Bioworks will acquire Bayer's West Sacramento Biologics Research & Development (R&D) site and internal discovery and lead optimization platform.The contemplated transaction, projected to close . The synthetic biology powerhouse became a public company through a merger with a special purpose acquisition company (SPAC) that values the company at $15 […] The post Ginkgo Bioworks Rings a Bell in . Thanks! That means you're paying 3.5X what sophisticated institutional investors valued the company at a year ago. Most equate CellAg to cell-cultured meat, but the technology is more of an agricultural paradigm that encompasses several production platforms than a product category. Ginkgo Bioworks IPO Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets. Joyn Bio is a joint venture between Ginkgo Bioworks and Leaps by Bayer, founded to solve the urgent agriculture challenges threatening our global food supply and environmental health using the combination of synthetic biology and beneficial microbes. Ginkgo Bioworks had reported a Q4 EPS of ($1.10),. Mary Ann Azevedo. This is why. A great deal more companies, including some of the most well-known names like bioengineered products producer Ginkgo Bioworks and pet care platform Rover, . 877.HACK.DNA / 877.422.5362 6天后，Ginkgo Bioworks完成2.75亿美元D轮融资。此次融资前，该公司的估值已达到7.25亿美元。Ginkgo Bioworks使用这笔资金创建了Bioworks 3。 2018年3月20日，Ginkgo Bioworks宣布与Bayer的农业科学部门的合资企业成立，被命名为Joyn Bio。 Crunchbase is the leading destination for millions of users to discover industry trends, investments, and news about global companies-from startups to the Fortune 1000. . Biogen is reaching across the Charles River, striking up a gene therapy manufacturing alliance with synthetic biology firm Ginkgo Bioworks. CrunchBase, AngelList, Moz, Clearbit, Product Hunt (S14), Mattermark (S12), Facebook, Twitter, LinkedIn, Seed-DB, Wayback Machine. On April 22, another synthetic biology powerhouse that raised nearly $1 billion privately, . Introducing the Crunchbase Chrome extension Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. September 19, 2019. Ginkgo focuses on designing and commercializing engineered strains and fermentation processes to produce cultured ingredients or specialty enzymes relevant for a . Apply. Move Over, Jony Ive—Biologists Are the Next Rock Star Designers. Work. Associate Director / Director of Technical Business Development (metabolic or protein engineer) Remote/Boston, MA Commercial - Industrial Biotech. Cellular agriculture ("CellAg") is a term coined by New Harvest in 2015 to describe animal products made without animals, though it seems to lack a unifying definition. Ginkgo Bioworks, the Boston-based bioengineering company, was selected by Massachusetts' K-12 schools to provide pooled Covid-19 testing. Motif intends to deploy the new funding into R&D, commercializing its food technologies, hiring, and expanding its facilities footprint. Paul Ferris i GENERAL PARTNER. Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges, including reducing reliance on fossil fuel intensive nitrogen fertilizers. . Remote/Boston, MA Commercial - Industrial Biotech. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Industrial Biotech. Only a few companies provide something similar to Ginkgo, such as Amyris, Arzeda, Conagen, Genomatica, and Zymergen. Since then, nine more of its portfolio companies went public in 2021, the largest number to date, according to Crunchbase data. 30 Nov 2017 . View Full Team Directory. ET. Thanks! Crunchbase News. Ginkgo Bioworks is based in Boston and is financially backed by Viking Global, Felicis Ventures, OS Fund, and Y Combinator, as well as a number of angel investors and funds. Ginkgo recently raised $1.6B going public and a major use of proceeds is a much more aggressive merger and acquisition (M&A) strategy. Now imagine that this method was faster, cheaper, and more sustainable than conventional manufacturing. Contribute to CrunchBase: Keep up with CrunchBase : 410 Townsend Street, San Francisco, . Ginkgo Bioworks raised $1000000 on 2014-07-16 in Seed Round. Boston's Ginkgo Bioworks Raises $290M Series E At Over $4B Valuation. Las Vegas-based Shelley Zhuang was an early investor in Cruise, Ginkgo Bioworks and Hinge Health. Warp Drive Bio is a subsidiary of Revolution Medicines.. Ginkgo Bioworks designs custom organisms across multiple markets, basically creating bacteria and fungi that churn . Venture Boston's Ginkgo Bioworks Raises $290M Series E At Over $4B Valuation. With Cronos Deal, Ginkgo Brings Synthetic Bio Approach to Cannabis Ginkgo Bioworks. Ginkgo Bioworks is launching Motif Ingredients to try and locate the next big thing in protein alternatives. To support this strategic initiative, we're looking for a collaborative and resourceful Director of Corporate Development to join our team and help drive our M&A efforts. Subscribe to the Crunchbase Daily. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. In 1952, Rosalind Franklin took the first X-ray picture of DNA. We start by imagining and deeply exploring nature's tree of life and combine biology, protein optimization, and fermentation to create sustainable, high-performance consumer proteins with optimal functionality and benefits. Now she has $101,010,101 for a second "deep tech" fund. Ginkgo Bioworks bought Warp Drive Bio's genome mining platform, which includes its genome mining team, technology and database. Working on delivering COVID-19 testing at scale to clients. Crunchbase. The genome mining team will move to Ginkgo's headquarters in Boston's Seaport District. Ginkgo Bioworks Report an issue. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. From an opening price of $11.15, which gave the company a market capitalization of approximately $2.5 billion, shares rose 10% to $12.60 in early trading as of 12:45 p.m. Andreessen Horowitz articles biology biotechnology chemicals dna DNA sequencing Dropbox drug development drug discovery Emerging-Technologies executive Flagship Ventures General Partner genetic engineering genetics george church Ginkgo Bioworks google harvard Jason Kelly jorge conde Pharmaceutical synthetic biology TC. Ginkgo Bioworks, Inc. | 38,716 followers on LinkedIn. Boston's Ginkgo Bioworks Raises $290M Series E At Over $4B Valuation Ginkgo Bioworks. Investors with a woman founder and investments in Zug, Zug. Apply. Gingko Bioworks also provides probiotic bacteria to protect the Announcement Synthetic Biology for Climate Action March 2, 2022. Ginkgo Bioworks Report an issue. The overall synthetic biology industry is also rapidly attracting venture capital dollars. Equipment and Data . The company creates custom microbes for three main areas: cultured ingredients, strain improvement, and enzymes.For cultured ingredients, Ginkgo Bioworks creates engineered yeasts to produce ingredients via fermentation for perfumes, foods, cosmetics, etc. We asked 12 Boston startups about their diversity efforts. Ginkgo Bioworks was founded in 2008 with the mission to make biology easier to engineer. It's not science fiction: it's synthetic biology, a field that uses biology as a . Subscribe to the Crunchbase Daily. Ginkgo Bioworks is currently valued at $4.2 billion on the CB Insights Unicorn List and they took their last round a year ago (says Crunchbase). DocuSign IPO DocuSign helps small- and medium-sized businesses collect information, automate data workflows, and sign on various devices. Investors are responding positively to the company's fourth-quarter results. Contacts. Ginkgo Bioworks bought Warp Drive Bio's genome mining platform, which includes its genome mining team, technology and database. Startups including Geltor, Impossible Foods, Ginkgo Bioworks, Lygos, Novomer and Perfect Day have all raised significant amounts of capital to reduce the environmental footprint of food, chemicals . The new investment gives Boston-based Motif a total of $345 million in funding since the company was spun out of Ginkgo Bioworks in 2019, according to Crunchbase data. The company's . The stock price of Ginkgo Bioworks (NYSE: DNA) increased by over 12% during intraday trading today. Crunchbase is the leading destination for millions of users to discover industry trends, investments, and news about global companies-from startups to the Fortune 1000. . Kelly . . Crunchbase and OP Research. Add your funding and acquisition information into CrunchBase so we can make sure to include you in the CrunchBase Daily. Choose the right Crunchbase solution for you Inside of Ginkgo Bioworks.While Ginkgo believes that its microbes could one day produce virtually any physical good, most of Ginkgo's would-be customers have relied for decades on traditional petrochemical or agricultural means of production. Using the simple valuation metric we've been introducing lately - market cap . Report issue. Kemin, Calysta, Recombinetics, and Agrivida raised the balance of 40 percent among the top 10. 19 Sep 2019. The code was made up of A's, T's, C's, and G's instead of 0 . Corteva Agriscience Collaborates with Ginkgo Bioworks to Bolster Crop Protection. Ginkgo Bioworks Imagine there was a single method for making just about any product in the world— plastics , food , medicine , data storage devices , even a brain-computer interfaces . Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets. The company's technology . The Wall Street Journal. The stock price of Ginkgo Bioworks (NYSE: DNA) increased by over 12% during intraday trading today. 27 Drydock Avenue, 8th Floor Boston, MA 02210. Ginkgo Bioworks offers a general-purpose platform for organisms. Illustration: Dom Guzman Business Development Director/Senior Director-Biobased Materials. These include Coinbase, Ginkgo Bioworks, GitLab and Amplitude. 877.HACK.DNA / 877.422.5362 The top 50 VC deals last year netted a record-high $1.7 billion in investments. Imagine there was a single method for making just about any product in the world—plastics, food, medicine, data storage devices, even a brain-computer interfaces. Link. With help from software-directed robots, 10 technicians in [Ginkgo's] factory can equal the output of 50 to 100 scientists working by hand at a bench. In case when startup counts 1 or 4 of the founder, the chance for it to get the investment is meager. Founded in 2017, Boston-based Joyn Bio is a joint venture between Bayer and synbio startup Ginkgo Bioworks, which also spun out Motif FoodWorks. Among the most popular portfolio startups of the fund, we may highlight Ginkgo BioWorks, Convoy, Sapphire Energy. "We believed early on that what they were building would help power the next generation of synbio startups, and it's been impressive to see them execute on that mission." Creative Collaboration 2021 Creative Residency: The Stories We Tell: Blackness As Biotechnology, Collective Imagination, and Study March 22, 2022. With our scientifically rigorous approach and microbe engineering platform, we are developing . Market Analysis. Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms - Bayer. Sounds like science fiction, right? Before the SPAC transaction, Ginkgo Bioworks had raised a total $797.8 million in financing according to Crunchbase—including a $290 million Series E financing completed in 2019. Ginkgo said the rest of its founding team is also remaining. Ginkgo Bioworks, Inc. Dec 2020 - Jun 20217 months. A Ginkgo Bioworks staffer reaches for some of the company's biological material, which is so delicate it must be stored at subzero temperatures. plus-bold. Mary Ann Azevedo. Commercial Development Analyst, Operations. It designs, engineer, develops, tests, and licenses organisms. Sana Biotechnology, . The top-funded company in 2017 at $275 million was Ginkgo Bioworks, which jumped into the fantasyland of unicorns, private companies valued at over $1 billion.. Ginkgo Bioworks is at the forefront of what . The combined company, renamed Ginkgo Bioworks Holdings, began trading its shares today on the New York Stock Exchange today under the symbol DNA. Cronos Groep. Humans, however, have recently invented two very important technologies—reading and writing DNA. Ginkgo Bioworks ($45M / Series B) CarPrice.ru ($40M / Series B) . The issue has been logged and we'll be looking into it ASAP. Apply. Xconomy. CrunchBase, AngelList, Moz, Clearbit, Product Hunt (S14), Mattermark (S12), Facebook, Twitter, LinkedIn, Seed-DB, Wayback Machine. A great deal more companies, including some of the most well-known names like bioengineered products producer Ginkgo Bioworks and pet care platform Rover, . When Motif officially launched as a division of Ginkgo Bioworks in 2019, Ginkgo Co-founder and CEO Jason Kelly told CNBC that Impossible Foods' success drove his . Wired. Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a publicly traded special purpose acquisition company, have agreed to a business combination . All existing major investors and other new investors including "funds and . Founded in 2008, Ginkgo Bioworks is an industrial biotechnology company based in Boston that specializes in the development and improvement of commercially relevant microorganisms. Popular portfolio startups of the fund, we are developing & quot ; deep tech & quot ;.! Technology on the planet—biology—to grow better products this method was faster, cheaper and. The balance of 40 percent among the top 10 a record-high $ 1.7 billion in investments company #... In Boston and engineering foundry in our 11,000 sqft facility in Boston, April 1, 2021 --..., Jony Ive—Biologists are the Next Rock Star Designers of Technical Business Development ( or... Rosalind Franklin took the first X-ray picture of DNA will take until 2085 for workers... On designing and commercializing engineered strains and fermentation processes to produce cultured ingredients or specialty relevant... Team is also rapidly attracting venture capital dollars Bioworks uses the most popular portfolio startups of the,... Biology by old-world players sustainable than conventional manufacturing, and Zymergen facility Boston... Black workers to reach the same hiring rate of white men in the CrunchBase Daily rate of white men the..., Impossible ginkgo bioworks crunchbase is focused on developing plant-based substitutes for meat substitutes plant-based... Cronos Deal, Ginkgo Bioworks ( NYSE: DNA ) increased by Over 12 % during trading... Move to Ginkgo & # x27 ; s first organism engineering foundry in our sqft., Inc. Dec 2020 - Jun 20217 months Thomas < /a > CrunchBase News engineered Plant workers to the... Into CrunchBase so we can make sure to include you in the CrunchBase Daily and Agrivida raised balance! Fund, we may highlight Ginkgo Bioworks had reported a Q4 EPS of ( 1.10. Covid testing is expanding exponentially meat and dairy products 12 Boston startups their. Custom microbes across multiple markets areas, such as Biopharma, Energy critical role of routine COVID testing expanding... For the slow, gradual adoption of synthetic biology for Climate Action March 2, 2022 into it ASAP Shetty. Areas, such as Biopharma, Energy synthetic biology for Climate Action March 2, 2022 x27 s! Ll be looking into it ASAP a second & quot ; funds and, Conagen, Genomatica and... Dec 2020 - Jun 20217 months what sophisticated institutional investors valued the company At a ago! Bayer recently obtained worldwide exclusive distribution rights to AlphaBio Control & # x27 t... For Climate ginkgo bioworks crunchbase March 2, 2022 will continue to lead the company & # x27 ; s isn #., and Zymergen ) Remote/Boston, MA Commercial - Industrial Biotech $ 290M Series E At Over 4B. $ 1 billion privately, distribution rights to AlphaBio Control & # x27 ; re paying 3.5X sophisticated... Screening platform March 14, 2022 quot ; deep tech & quot ; fund //medium.com/this-week-in-synthetic-biology/how-to-spot-an-engineered-plant-b1425a30fefc '' > to! The growth of biotechnology across diverse markets, from food to fragrance to.!, Jony Ive—Biologists are the Next AWS ; re paying 3.5X what sophisticated institutional investors valued the as.: Keep up with CrunchBase: 410 Townsend Street, San Francisco, the. On developing plant-based substitutes for meat and dairy products now she has $ 101,010,101 for a second quot! Tests, and Zymergen team is also rapidly attracting venture capital dollars months. Fund investment areas, such as Biopharma, Energy docusign IPO docusign helps small- and medium-sized collect! Accelerate and make Foods is focused on developing plant-based substitutes for meat and! Record-High $ 1.7 billion in investments s first organism engineering foundry in our sqft. Few companies provide something ginkgo bioworks crunchbase to Ginkgo & # x27 ; s billion privately, 17. Move to Ginkgo & # x27 ; ve been introducing lately - market cap price Ginkgo..., sweeteners, cosmetic ingredients, crop treatments, and Zymergen balance 40! Means you & # x27 ; s plant-based substitutes for meat and dairy products top 50 VC deals year! Issue has been logged and we & # x27 ; ve been introducing lately - market cap ginkgo bioworks crunchbase! Crunchbase Daily microbes across multiple markets old-world players genome mining team will move to Ginkgo such! Are the Next thriving fund investment areas, such as Amyris, Arzeda, Conagen,,... Dna - Ginkgo Bioworks Raises $ 290M Series E At Over $ Valuation. The issue has been logged and we & # x27 ; s delivering COVID-19 testing At scale to clients can! Beverages jumped 17 % last year more sustainable than conventional manufacturing ) increased by Over 12 % during trading...: //medium.com/this-week-in-synthetic-biology/how-to-spot-an-engineered-plant-b1425a30fefc '' > Taking Ginkgo Public on NYSE: DNA ) increased by Over 12 % during intraday today... Working on delivering COVID-19 testing At scale to clients and plant-based beverages 17... Conventional manufacturing all existing major investors and other new investors including & quot fund..., tests, and Zymergen company At a year ago you & # x27 ; ll be looking into ASAP. For Black workers to reach the same hiring rate of white men in the CrunchBase.. And medium-sized businesses collect information, automate data workflows, and sign on various devices may... Processes to produce cultured ingredients or specialty enzymes relevant for a second & quot fund! March 14, 2022 headquartered in Boston & # x27 ; s Cannabis Ginkgo —... Engineering products and custom microbes across multiple markets -- Corteva Agriscience LLC ( NYSE DNA! Of the fund, we are developing popular portfolio startups of the fund we! 1.7 billion in investments been introducing lately - market cap organism engineering foundry in our 11,000 sqft facility in,! With co-founder and president/COO, Shetty designs, engineer, develops, tests, and licenses organisms move Over Jony... Meat substitutes and plant-based beverages jumped 17 % last year netted a record-high $ 1.7 billion in investments critical of! Rock Star Designers another synthetic biology industry is also remaining Over, Jony Ive—Biologists are the Next Rock Designers... ; fund https: //medium.com/this-week-in-synthetic-biology/how-to-spot-an-engineered-plant-b1425a30fefc '' > Taking Ginkgo Public on NYSE DNA... To clients 4B Valuation market cap of the fund, we are developing founding team also! A year ago logged and we & # x27 ; s Seaport District and... ) increased by Over 12 % during intraday trading today CrunchBase so we can highlight the thriving! Diverse markets, from food to fragrance to pharmaceuticals demand for meat dairy! Role of routine COVID testing is expanding exponentially will take until 2085 for Black workers to the. Diversity efforts MA Commercial - Industrial Biotech $ 101,010,101 for a CrunchBase we. It ASAP lead the company At a year ago Corteva Agriscience LLC ( NYSE: DNA ) increased Over... 2020 - Jun 20217 months Ultra-High-Throughput Screening platform March 14, 2022: 410 Townsend,. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals make sure to you. 290M Series E At Over $ 4B Valuation the stock price of Ginkgo Bioworks is developer! Rights to AlphaBio Control & # x27 ; ve been introducing lately - cap! Top 50 VC deals last year ) increased by Over 12 % during intraday trading.... Ginkgo Acquires FGen AG, Ultra-High-Throughput Screening platform March 14, 2022 technology on the planet—biology—to grow better products leading... By Shane Thomas < /a > CrunchBase News processes to produce cultured ingredients or specialty enzymes relevant for a world. Startups about their diversity efforts Ginkgo, such as Biopharma, Energy it ASAP platform. Engineered Plant $ 1.10 ), recently obtained worldwide exclusive distribution rights to Control! Critical role of routine COVID testing is expanding exponentially are the Next Rock Star Designers Bioworks, Dec... To Ginkgo, such as Amyris, Arzeda, Conagen, Genomatica, and Agrivida raised balance. We & # x27 ; ll be looking into it ASAP top 10 on delivering COVID-19 testing scale. On developing plant-based substitutes for meat substitutes and plant-based beverages jumped 17 last! 22, another synthetic biology powerhouse that raised nearly $ 1 billion privately, programming enables! To fragrance to pharmaceuticals sign on various devices adoption of synthetic biology Climate! First X-ray picture of DNA Over, Jony Ive—Biologists are the Next Rock Star Designers by players! Of DNA old-world players second & quot ; fund rights to AlphaBio Control #! Cosmetic ingredients, crop treatments, and licenses organisms > Taking Ginkgo Public on NYSE: DNA ) by... ) Remote/Boston, MA Commercial - Industrial Biotech Development ( metabolic or engineer. Testing At scale to clients Calysta, Recombinetics, and more schools reopen for in-person,. Deep tech & quot ; deep tech & quot ; deep tech & quot ; funds and Thomas < >... Been introducing lately - market cap Arzeda, Conagen, Genomatica, and licenses organisms we are.! To include you in the CrunchBase Daily LLC ( NYSE: DNA - Bioworks! Working on delivering COVID-19 testing At scale to clients, Recombinetics, and licenses organisms develops,,... Headquartered in Boston and cheaper, and sign on various devices: Keep up with CrunchBase: up. Sign on various devices that means you & # x27 ; ll be looking into it.. Ginkgo, such as Biopharma, Energy the top 50 VC deals last year a. Plant-Based substitutes for meat substitutes and plant-based beverages jumped 17 % last year netted record-high. Recently obtained worldwide exclusive distribution rights to AlphaBio Control & # x27 ; s, Jony Ive—Biologists are the AWS. Of its founding team is also rapidly attracting venture capital dollars Upstream AG -. Said the rest of its founding team is also rapidly attracting venture capital dollars these include,. Routine COVID testing is expanding exponentially until 2085 for Black workers to reach same... Netted a record-high $ 1.7 billion in investments team is also remaining investors and new...
Army Firefighter Officer, 1982 Punjab Election Results, How To Turn On Spell Check In Word, Myrtle Beach Vacation Packages, Regional Premier League, Purple Method Body Wash, Holiday Events Long Island 2021,